I am opening a first position in Wolters Kluwer today because the market is making a fundamental mistake here. The company is trading 61% below its high for the year - not because of an operational deterioration, but because an AI panic sell-off has hit a 190 year old compounder that generates €6.1bn in sales with 83% recurring revenue, a ROIC of 26% and an FCF yield of ~10%.
The management itself is buying back at €64 - as part of a €500m buyback program - sending the clearest signal a board can send: the stock is too cheap.
My entry with 50% of the budget is deliberately not an all-or-nothing decision. I expect AI headlines to generate further pressure in the short term and am therefore holding back two further tranches.
If the share price falls to ~€59 - close to the 52-week low and the Morningstar 5-star price of €57 - I will top up with a further 33% of the budget.
I will either use a third, smaller tranche with the remaining ~17% in the event of a further setback below €55 or use it as a momentum top-up in August after the H1 figures if the guidance is confirmed.
I have defined three specific levels for my profits. At €90, I sell 25% of my position - this corresponds to the first price recovery, covers part of my costs and takes pressure off the position. At €112, the analyst consensus price target, I sell a further 40% - this is the most likely price level over the next 12-24 months and corresponds to a return of ~83% on my average purchase price of ~€61.50.
I am keeping the remainder open as a long-term position as long as the business model is intact.
My three scenarios with clear figures: In the bullish case - probability 35% - Wolters Kluwer accelerates the cloud transition, AI proves to be a tailwind for new products, and the share price runs to ~€170 by 2028, up ~165%.
In the neutral case - probability 45% - business continues as before, organic growth remains at 5-6%, and the share price normalizes to ~€105, up around 64%.
In the bearish case - probability 20% - structural AI pressure on the Legal and Health segments sets in, margins come under pressure and the share price falls to ~€57, which corresponds to a drop of around 11%.
The weighted expected value across all three scenarios is ~€118, i.e. around 84% above today's entry price.
My hard stop loss is at €52 - the position is automatically closed there, as a break of this level would indicate a fundamental, not just sentiment-driven deterioration.
